Nexus AG: Double-digit Sales and Earnings Growth again in Fiscal Year 2017

Donaueschingen (pta013/06.03.2018/08:30 UTC+1) NEXUS AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11.2 % and earnings before interest and taxes (EBIT) by 21.8 % in the fiscal year 2017. As a result, NEXUS Group continued its successful positive sales and earnings trend of recent years.

In 2017, sales improved by 11.2 % from KEUR 107,051 to KEUR 119,083. The international share of total business volume was 44.4 % (previous year: 48.8 %) and reached KEUR 52,905 following KEUR 52,227 in the previous year.

The Group result before taxes (EBT) increased considerably by 21.8 % to KEUR 13,282 (previous year: KEUR 10,908). The result before interest and taxes (EBIT) reached KEUR 13,316 following KEUR 10,929 in the previous year (+21.8 %). EBITA increased by 14.5 % from KEUR 14,035 (2016) to KEUR 16,075. The EBITDA increased by 12.8 % to KEUR 23,718 (previous year: KEUR 21,021) during the reporting period.

Particularly noteworthy is the operating cash flow, which increased by 31.0 % to KEUR 21,677 (previous year: KEUR 16,542).

NEXUS AG had equity capital amounting to KEUR 103,009 as of 31 December 2017 (previous year: KEUR 95,802). Consequently, the equity capital rate is 68.1 % (previous year: 68.6 %). There are no essential bank liabilities. At the end of 2017, the company had cash resources at its disposal in the amount of KEUR 28,385 (previous year: KEUR 18,856). This demonstrates that NEXUS AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.

At the annual general meeting on 27 April 2018, the Supervisory Board and the Executive Board will propose to pay a dividend of 16 cents per share.

The detailed Annual Report 2017 can be found on our homepage at:
www.nexus-ag.de - Unternehmen - Investor Relations - Finanzbericht

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Dr. Patrick Stein
Phone:	+49 771 22960-201
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Munich, Stuttgart